A new study has shown that AstraZeneca's Evusheld therapy provides protection against COVID-19 for at least six months. The antibody cocktail produced by the British-Swedish multinational pharmaceutical and biotechnology company offers 83 per cent protection against the novel virus.

AstraZeneca's Evusheld therapy provides protection against COVID-19 for at least 6 months

azd7442

Azd7442, News on Azd7442, stories on Azd7442, articles on Azd7442, Azd7442 stories at Wion, Azd7442 news, Azd7442 latest news